Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin or Mirabegron with Local Estrogen vs Combination for Refractory OAB
NCT06479720Phase 4Recruiting
- Sponsor
- Mackay Memorial Hospital
- Start
- Jun 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Estrogen vaginal cream in overactive bladder (OAB), sponsored by Mackay Memorial Hospital. Started Jun 2022; status: recruiting.
02
Drugs
Estrogen vaginal cream
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT06479720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06479720.